TXTM Stock Analysis
TX
Uncovered
Protext Mobility Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
ProText Mobility, Inc. engages in the development of pharmaceutical applications for botanical drugs. The company is headquartered in Delray Beach, Florida. The company went IPO on 2003-08-21. The firm is engaged in the research, clinical testing and commercialization of bioavailable botanical products, which includes all-natural ingredients formulated for nutraceutical and pharmaceutical applications. The firm is focused on the development of pharmaceutical applications for botanical drugs and has the license to develop Phytofare in botanical drug applications. The Phytofare is bioavailable extract produced from live green tea leaves that has been clinically proven in double-blind human trials to have greater bioavailability over generic extract. The Company’s subsidiaries include EchoMetrix, Plandai Biotechnology and Cannabis Biosciences, Inc.